GENERAL ORTHOPAEDICS
Autologous platelet-rich plasma use reveals no benefit in improving pain and function
This report has been verified
by one or more authors of the
original publication.
J Bone Joint Surg Am. 2012 Feb 15;94(4):298-307. doi: 10.2106/JBJS.K.00154
23 randomized controlled trials (RCTs) and 10 prospective cohort studies were identified to evaluate the efficacy of autologous blood concentrates in decreasing pain and improving healing and function for patients with orthopaedic bone and soft-tissue injuries. Results from both types of studies indicated that the use of platelet-rich plasma provided no significant benefit up to and including 24 months.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
